Search
Selected: H

Heteroaryl substituted phenyl isoxazole sulfonamide endothelin a

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl substituted phenylethenyl compounds having retinoid-l

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl substituted pyrazole modulators of metabotropic...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl substituted pyrrole modulators of metabotropic...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl substituted pyrrole modulators of metabotropic...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl substituted pyrrolo[2,3-b]pyridines and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl substituted spirocyclic sulfamides for inhibition...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl substituted spriocyclic sulfamides for inhibition...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl substituted tetrazole modulators of metabotrophic...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl substituted triazole modulators of metabotropic...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl tropane derivatives as superior ligands for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl urea neuropeptide Y Y5 receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl urea neuropeptide Y Y5 receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl urea neuropeptide Y Y5 receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl, heterocyclic and aryl compounds which inhibit...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl, heterocyclic and aryl compounds which inhibit...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl, heterocyclic and aryl compounds which inhibit...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl, heterocyclic and aryl compounds which inhibit...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl, heterocyclic and aryl compounds which inhibit...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Heteroaryl, heterocyclic and aryl compounds which inhibit...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.